Viewing Study NCT04382300


Ignite Creation Date: 2025-12-26 @ 12:16 PM
Ignite Modification Date: 2026-03-01 @ 12:32 PM
Study NCT ID: NCT04382300
Status: UNKNOWN
Last Update Posted: 2021-01-28
First Post: 2020-04-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions
Sponsor: Shanghai Chest Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: MA-NSCLC-II-005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators